Moogene Medi Co Ltd
322970
Company Profile
Business description
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.
Contact
670, Daewangpangyo-ro, Bundang-gu
U-space 2 A-505
Gyeonggi-do
Seongnam-si
KORT: +82 316286886
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
18
Stocks News & Analysis
stocks
Earnings up but shares overvalued for ASX gold miner
Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks
Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%
We see faster cloud growth and improved longer-term profitability for Alphabet.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,351.90 | 4.90 | -0.05% |
| CAC 40 | 8,252.04 | 26.41 | 0.32% |
| DAX 40 | 24,280.99 | 41.10 | 0.17% |
| Dow JONES (US) | 47,439.24 | 232.12 | 0.49% |
| FTSE 100 | 9,663.05 | 17.43 | 0.18% |
| HKSE | 26,433.70 | 273.55 | 1.05% |
| NASDAQ | 23,533.68 | 328.81 | 1.42% |
| Nikkei 225 | 50,512.32 | 1,212.67 | 2.46% |
| NZX 50 Index | 13,391.59 | 14.49 | 0.11% |
| S&P 500 | 6,849.35 | 57.66 | 0.85% |
| S&P/ASX 200 | 9,055.60 | 2.20 | -0.02% |
| SSE Composite Index | 3,996.94 | 46.63 | 1.18% |